Sage Journals: Discover world-class research

Open access

Review article

First published 2020

Targeting non-small cell lung cancer: driver mutation beyond epidermal growth factor mutation and anaplastic lymphoma kinase fusion

Quincy S. Chu

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2024

Analysis of outcomes in resected early-stage NSCLC with rare targetable driver mutations

Nadia Ghazali, Jamie Feng, Katrina Hueniken [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2015-12

Driver Missense Mutation Identification Using Feature Selection and Model Fusion

Ahmed T. Soliman, Tao Meng, Shu-Ching Chen [...]

Journal of Computational Biology

Open access

Research article

First published 2020

PD-L1 expression with respect to driver mutations in non-small cell lung cancer in an Asian population: a large study of 1370 cases in China

Caichen Li, Jun Liu, Zhanhong Xie [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2020-12

Clinical Effect of Driver Mutations of KRAS,CDKN2A/P16,TP53,and SMAD4 in Pancreatic Cancer: A Meta-Analysis

Yujun Gu, Yayun Ji, Hui Jiang [...]

Genetic Testing and Molecular Biomarkers

Open access

Research article

First published 2022-7

Development of an Accessible Gene Expression Bioinformatics Pipeline to Study Driver Mutations of Colorectal Cancer

Lisa van den Driest, Caroline H. Johnson, Nicholas J.W. Rattray [...]

Alternatives to Laboratory Animals

Open access

Review article

First published 2026

Actionable driver gene alterations in early-stage non-small cell lung cancer: a review

Ilaria Attili, Pasquale Pisapia, Gianluca Spitaleri [...]

Therapeutic Advances in Medical Oncology

Retricted access

Case report

First published 2020-3

An advanced c-MET-amplified NSCLC patient that was treated with crizotinib

Mesut Yilmaz, Sermin Guven Mese, Ibrahim Cil [...]

Journal of Oncology Pharmacy Practice

Free access

Research article

First published 2018-2

Globo H expression is associated with driver mutations and PD-L1 expressions in stage I non-small cell lung cancer

Ching-Yao Yang, Mong-Wei Lin, Yih-Leong Chang [...]

Cancer Biomarkers

Retricted access

Review article

First published 2023-10

Outcome of non-small-cell lung cancer with driven mutations treated with anti-PD-(L)1 agents: A systematic review

Andrea Luciani, Antonio Ghidini, Karen Borgonovo [...]

Tumori Journal

Search results